-
ESI launches ScreenRx, offers preview of 2011 'Drug Trend Report'
ST. LOUIS — Fresh off the heels of its merger with Medco Health Solutions, pharmacy benefit manager Express Scripts announced Monday the launch of a medication nonadherence detection system and offered a preview of its annual "Drug Trend Report."
-
FDA requests more data for Baxter, Halozyme biotech treatment
DEERFIELD, Ill. — The Food and Drug Administration is requesting additional data from two drug makers for a treatment for immune system disorders.
Baxter and Halozyme said the FDA wanted more data to review their application for HyQ, a combination of immune globulin and recombinant human hyaluronidase.
The companies said they would work to develop studies to provide additional data to address the agency's concerns.